Ligand Pharmaceuticals reported $98.81M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acorda Therapeutics ACOR:US USD 37.95M 4.07M
Agenus AGEN:US USD 188.95M 15.88M
Amgen AMGN:US USD 15.69B 1.36B
Anika Therapeutics ANIK:US USD 27.91M 1.56M
Arrowhead Research ARWR:US USD 122.01M 16.84M
Baxter International BAX:US USD 4.74B 1.04B
Clovis Oncology CLVS:US USD 747.87M 626.6M
Enanta Pharmaceuticals ENTA:US USD 23M 6.83M
Endo International Ordinary Shares ENDP:US USD 543.05M 638.62M
Gilead Sciences GILD:US USD 11.24B 814M
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
Glaxosmithkline GSK:US GBP 22.81B 1.86B
Harsco HSC:US USD 597.28M 5.58M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Immunogen IMGN:US USD 121.86M 18.22M
Insmed INSM:US USD 190.24M 52.59M
Intrexon XON:US USD 78.64M 26.22M
Karyopharm Therapeutics KPTI:US USD 72M 10.24M
Lannett LCI:US USD 112.22M 2.07M
Ligand Pharmaceuticals LGND:US USD 98.81M 36.43M
Macrogenics MGNX:US USD 48.61M 1.43M
Pacira Pharmaceuticals PCRX:US USD 147.77M 16.25M
Rigel Pharmaceuticals RIGL:US USD 65.21M 17.95M
Sangamo Biosciences SGMO:US USD 111.71M 10.65M
Spectrum Pharmaceuticals SPPI:US USD 49.62M 8.58M
Teva Pharmaceutical Industries TEVA:US USD 11.47B 65M
Veracyte VCYT:US USD 62.61M 4.26M